NDSU Campus Updates
NDSU's Department of Public Health is providing free COVID-19 home test kits to all students, faculty, and staff at NDSU. You can pick up test kits at the following locations:
- NDSU Bookstore
- NDSU Library
- Barry Hall - room 102
- Renaissance Hall - room 108
- NDSU Student Health Service
Students can receive free Pfizer and Moderna COVID vaccinations at Student Health Service. Call 701-231-7331 to schedule your appointment.
About the COVID-19 Vaccine
COVID-19 vaccines are safe and effective. Individuals that are up-to-date on their vaccines are less likely to have symptomatic infection, severe disease, hospitalization, and death compared to nonvaccinated individuals. Getting vaccinated is the best way to protect ourselves and those around us from COVID-19. Read the latest studies.
Most people 6 months of age and older are eligible to be vaccinated against COVID-19. The Pfizer-BioNTech COVID-19 vaccine (known as Comirnaty, pronounded koe-mire'-na-tee) and the Moderna vaccine (known as Spikevax) has full FDA approval for individuals 6 months of age and older. COVID-19 Vaccine Schedule for All Ages
The public can be very confident that these vaccines meet high standards for safety, effectiveness, and manufacturing quality . Read more about the FDA approval and the Biologics License Applications (BLA) process.
While some people may experience mild symptoms after receiving the vaccine, serious adverse events are rare. Medical providers and vaccine experts believe that the benefits of receiving the COVID-19 vaccine greatly outweigh the risks.
COVID-19 vaccines were studied in clinical trials in tens of thousands of people from diverse ages, races and ethnicities. Manufacturers had to meet rigorous safety and efficacy standards before their vaccines were authorized for use in the U.S. Today, 657 million+ people in the U.S. have received COVID-19 vaccines under the most intensive safety monitoring in our history – reassuring us that COVID-19 vaccines are safe and effective.
Available Vaccines & Eligibility
Currently, there are four COVID-19 vaccines authorized for use in the US: Moderna, Pfizer, Johnson & Johnson (Janssen), and Novavax. Moderna and Pfizer’s COVID-19 vaccines are mRNA (messenger RNA) vaccines. Johnson & Johnson is a non-replicating viral vector vaccine. Novavax is a protein subunit vaccine. These vaccines teach your body to fight off COVID-19. Vaccines do not stick around in our body for long, nor do they give you COVID-19. Rather, if we come in contact with the virus that causes COVID-19, the vaccine has prepped our immune system to recognize the virus and fight off the infection more effectively.
Most children and adults age 6 months and older are now eligible to receive the COVID-19 vaccine:
- Pfizer-BioNTech (2 dose primary series, given 21 days apart): Ages 6 months+
- For children 6 months to 5 years, 3 doses (including one bivalent booster dose) is considered primary series
- Moderna (2 dose primary series, given 28 days apart): Ages 6 months+
- Novavax (2 dose primary series, given 21 days apart): Ages 12+
- Johnson & Johnson/Janssen (1 dose primary series): Ages 18+
- The CDC recommends Pfizer and Modern (mRNA vaccines) and Novavax (protein subunit vaccines) over the J&J vaccine. The J&J/Janssen COVID-19 vaccine may be considered in some situations, including for persons who: Had a severe reaction after an mRNA or protein subunit vaccine dose or who have a severe allergy to an ingredient of Pfizer-BioNTech or Moderna.
For immunocompetent individuals (individuals with no underlying condition that puts them at risk for severe covid-19), you are considered fully vaccinated after 2 weeks of your second dose. Some immunocompromised individuals should receive an additional dose of the vaccine to complete their primary series. To see CDC recommendations for people who are moderately or severely immunocompromised check out the CDC website. You are considered up-to-date after your booster dose.
On September 1, 2022, the CDC issued new recommendations for COVID-19 boosters, after the FDA authorized updated booster formulas from both Pfizer and Moderna. The CDC recommends that everyone who is eligible stay up-to-date on vaccination. Regardless of the vaccine brand given for a primary series, fully vaccinated people aged 6 months and older should receive a bivalent booster dose at least two months after their last COVID vaccine. This includes after either the 2nd dose of a primary series or a booster(s).
People 6 months and older are eligible for the Pfizer/BioNTech and Moderna bivalent booster.
Some immunocompromised individuals or individuals aged 65+ may have had two monovalent (original formula) booster doses. It doesn't matter how many monovalent booster doses a person has had. They should still get a bivalent booster two months after their last vaccine.
About Bivalent Boosters
These new boosters contain an updated bivalent formula that both boosts immunity against the original coronavirus strain and also protects against the newer Omicron variants that account for most of the current cases. Updated boosters are intended to provide optimal protection against the virus and address waning vaccine effectiveness over time.
As per the CDC’s recommendations, the new bivalent booster replaces the existing monovalent vaccine booster, therefore that vaccine will no longer be authorized for use as booster doses in people age 12 and up.
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communication Collaborative (publichealthcollaborative.org)
Get Your Vaccine
COVID-19 Vaccine Locator or text GETVAX to 438829 to find a vaccine near you!